Measuring and Valuing Health Benefits for Economic Evaluation by John BrazierMeasuring and Valuing Health Benefits for Economic Evaluation by John Brazier

Measuring and Valuing Health Benefits for Economic Evaluation

byJohn Brazier, Julie Ratcliffe, Joshua Saloman

Paperback | December 10, 2016

Pricing and Purchase Info


Earn 358 plum® points

Prices and offers may vary in store


Ships within 1-3 weeks

Ships free on orders over $25

Not available in stores


There are not enough resources in health care systems around the world to fund all technically feasible and potentially beneficial health care interventions. Difficult choices have to be made, and economic evaluation offers a systematic and transparent process for informing such choices. A keycomponent of economic evaluation is how to value the benefits of health care in a way that permits comparison between health care interventions, such as through costs per quality-adjusted life years (QALY).Measuring and Valuing Health Benefits for Economic Evaluation examines the measurement and valuation of health benefits, reviews the explosion of theoretical and empirical work in the field, and explores an area of research that continues to be a major source of debate. It addresses the keyquestions in the field including: the definition of health, the techniques of valuation, who should provide the values, techniques for modelling health state values, the appropriateness of tools in children and vulnerable groups, cross cultural issues, and the problem of choosing the rightinstrument.This new edition contains updated empirical examples and practical applications, which help to clarify the readers understanding of real world contexts. It features a glossary containing the common terms used by practitioners, and has been updated to cover new measures of health and wellbeing, suchas ICECAP, ASCOT and AQOL. It takes into account new research into the social weighting of a QALY, the rising use of ordinal valuation techniques, use of the internet to collect data, and the use of health state utility values in cost effectiveness models.This is an ideal resource for anyone wishing to gain a specialised understanding of health benefit measurement in economic evaluation, especially those working in the fields of health economics, public sector economics, pharmacoeconomics, health services research, public health, and quality of liferesearch.
John Brazier is a Professor of Health Economics at the University of Sheffield. With more than twenty five years' experience of conducting economic evaluations for policy makers, he has a particular interest in the measurement and valuation of health where he has published widely (n200). He has developed generic (SF-6D) and condition p...
Title:Measuring and Valuing Health Benefits for Economic EvaluationFormat:PaperbackDimensions:372 pages, 9.21 × 6.14 × 0.75 inPublished:December 10, 2016Publisher:Oxford University PressLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0198725922

ISBN - 13:9780198725923

Look for similar items by category:


Table of Contents

1. The purpose and scope of this book2. Introduction to the measurement and valuation of health3. Foundations in welfare economics and utility theory: what should be valued?4. Valuing health5. Modelling health state valuation data6. Using ordinal response data to estimate cardinal values for health states7. Methods for obtaining health state utility values: generic preference-based measures of health8. Alternatives to generic preference-based measures: mapping, condition specific measures, bolt-ons, vignettes, direct utility assessment and well-being9. Design and analysis of health state valuation data for model-based economic evaluations and for economic evaluations alongside clinical trials10. A QALY is a QALY is a QALY-or is it not?11. Measuring and valuing health: an international perspective12. Conclusions: measurement and valuation of health

Editorial Reviews

Review from previous edition: "This new text is indeed timely...[it's] a useful addition to the literature on economic evaluation." --Pharmacoeconomics, Vol 25, No 4 Mar 2007